RMD · Resmed Inc
$240.33
+4.57 (+1.94%)
At close · Aug 28
Market Cap
$34.67B
Shares
144.25M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-17 | 2026-08-13 | |
| 10-K | 2026-08-13 | 2026-06-30 | |
| 8-K | 2026-08-06 | — | |
| 8-K | 2026-07-07 | 2026-06-30 | |
| Investor Event Transcript | 2026-06-02 | 2025-12-31 | |
| 10-Q | 2026-05-01 | 2026-03-31 | |
| 8-K | 2026-04-30 | — | |
| 8-K | 2026-04-30 | 2026-04-24 | |
| 10-Q | 2026-01-30 | 2025-12-31 | |
| 8-K | 2026-01-29 | — | |
| 8-K | 2025-11-20 | 2025-11-19 | |
| 10-Q | 2025-10-31 | 2025-09-30 | |
| 8-K | 2025-10-30 | — | |
| DEF 14A | 2025-10-02 | 2025-06-30 | |
| 8-K | 2025-08-18 | 2025-08-15 | |
| 10-K | 2025-08-08 | 2025-06-30 | |
| 8-K | 2025-08-01 | 2025-07-28 | |
| 8-K | 2025-07-31 | — | |
| 10-Q | 2025-04-24 | 2025-03-31 | |
| 8-K | 2025-04-23 | — | |
| 10-Q | 2025-01-31 | 2024-12-31 | |
| 8-K | 2025-01-30 | — | |
| 8-K | 2024-11-21 | 2024-11-20 | |
| 10-Q | 2024-10-25 | 2024-09-30 | |
| 8-K | 2024-10-24 | — | |
| DEF 14A | 2024-10-03 | 2024-06-30 | |
| 8-K | 2024-08-16 | 2024-08-15 | |
| 10-K | 2024-08-09 | 2024-06-30 | |
| 8-K | 2024-08-01 | — | |
| 10-Q | 2024-04-26 | 2024-03-31 | |
| 8-K | 2024-04-25 | — | |
| 10-Q | 2024-01-25 | 2023-12-31 | |
| 8-K | 2024-01-24 | — | |
| 8-K | 2023-11-20 | 2023-11-16 | |
| 8-K | 2023-11-09 | — | |
| 10-Q | 2023-10-27 | 2023-09-30 | |
| 8-K | 2023-10-26 | — | |
| DEF 14A | 2023-10-05 | 2023-06-30 | |
| 10-K | 2023-08-11 | 2023-06-30 | |
| 8-K | 2023-08-03 | — | |
| 10-Q | 2023-04-28 | 2023-03-31 | |
| 8-K | 2023-04-27 | — | |
| 8-K | 2023-03-30 | 2023-03-29 | |
| 10-Q | 2023-01-27 | 2022-12-31 | |
| 8-K | 2023-01-26 | 2023-01-25 | |
| 8-K | 2022-11-17 | 2022-11-16 | |
| 10-Q | 2022-10-28 | 2022-09-30 | |
| 8-K | 2022-10-27 | — | |
| DEF 14A | 2022-10-05 | — | |
| 8-K/A | 2022-08-12 | 2022-06-13 |
Showing 1–50 of 87 filings
Key facts
CIK
943819
CUSIP
761152107
13F (30d)
601 filings
575 filers
Visit website
Investor relations